AOD9604
Limited evidence — Early or sparse dataWhat it is
A modified GH fragment trialled for obesity that did not meet weight-loss endpoints; studied since for cartilage/other uses.
AOD-9604 is a modified GH fragment that was trialled for obesity and did not meet its weight-loss endpoints; it has since been studied for cartilage and other uses.
Research context
Studied in relation to:
- Metabolic/cartilage research
Points in its favour in the literature:
- Some human safety data from trials
Caveats and unknowns:
- Failed its weight-loss trials
- Benefit unproven
- Unlicensed for human use
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Trials/research used ~300 mcg daily.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | 5AD |
| 10mg | 10AD |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.